首页|糖尿病视网膜病变的中药治疗进展

糖尿病视网膜病变的中药治疗进展

扫码查看
糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病患者发病率较高的并发症之一,是糖尿病患者失明的主因。由于老年群体全身器官功能进行性退变,是糖尿病的主要群体,临床糖尿病相关并发症的报道多集中在心脑血管疾病,导致糖尿病患者对DR认识不足。随着DR患者不断地增多,临床越来越关注DR,早发现、早诊断、早治疗是预防DR患者失明的主要途径。由于DR患者使用西药治疗易出现不良反应和耐药性,导致临床应用受限。随着中医的发展,临床越来越关注中药治疗DR。本文从中医对DR的认识、DR的中药治疗、中药提取物治疗DR的药理机制 3 个方面进行综述,旨在为临床治疗DR提供参考。
Progress of Traditional Chinese Medicine Treatment of Diabetic Retinopathy
Diabetic retinopathy(DR)is a complication with high incidence rate in diabetes patients,and it is the main cause of blindness in diabetes patients.Due to the progressive degeneration of whole body organ function of elderly population,they are the main group of diabetes.The reports of clinical diabetes related complications mostly focus on cardiovascular and cerebrovascular diseases,leading to the lack of awareness of DR in diabetes patients.With the increasing number of DR patients,clinical attention is increasingly focused on DR,early detection,early diagnosis.And early treatment are the main ways to prevent blindness in DR patients.Due to the use of western medicine in DR patients,adverse reactions and drug resistance are prone to occur,leading to limited clinical application.With the development of traditional Chinese medicine,clinical attention is increasingly focused on the treatment of DR with traditional Chinese medicine.This article reviewed the understanding of DR in traditional Chinese medicine,the traditional Chinese medicine treatment of DR,and the pharmacological mechanism of traditional Chinese medicine extracts in treating DR,aiming to provide reference for clinical treatment of DR.

Diabetic retinopathyTraditional Chinese medicineChinese herbal extractPharmacological mechanism

房凌云

展开 >

菏泽市中医医院 山东 菏泽 274035

糖尿病视网膜病变 中药 中药提取物 药理机制

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(36)